Gland Pharma Ltd.NSE: GLAND

Press Release Apr 30 2025

· Issued by Gland Pharma Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-30-2025-10

Gland Pharma Limited has informed the Exchange regarding a press release dated April 30, 2025, titled "Gland Pharma Receives Approval from USFDA for Latanoprostene Bunod Ophthalmic Solution".

View Attachment

6ix hasn’t read this filing yet.

Gland Pharma Ltd. on 6ix

Earlier from Gland Pharma

Later from Gland Pharma

All Gland Pharma news releases